Blood Tube Draw Order: Colors, Additives & Quick Chart

1. Venous Order of Draw Chart: Colors, Additives and Tests

The lab draw order organizes blood collection tubes by additive group. This chart brings the sequence and common test examples together. It uses familiar U.S. color conventions; the receiving laboratory’s test directory determines the accepted container and specimen.

Sequence and grouping: CLSI public guidance and Greiner Bio-One’s manufacturer chart.^[1][4] Test examples identify common uses, not interchangeable tubes or a complete test directory.^{[8][9][10][17][18]}

Example: if the orders require citrate plasma, serum and an EDTA whole-blood specimen, collect those three groups in that order. There is no reason to add a culture bottle, heparin tube or gray tube solely to complete a memorized list.

2. Which Color Tube Is Used for Which Test?

A useful answer connects color + additive + specimen + test requirement. “Chemistry” or “blood test” alone is too broad to select a container. Serum is obtained after blood clots; anticoagulated blood can provide plasma after processing, while whole-blood tests retain the cellular components.^[8]

Blood culture bottles and light-blue tubes

Blood cultures belong first among the routine groups. Bottle color, collection volume and aerobic-versus-anaerobic bottle order are system-specific; this article’s six-group chart does not establish those details. Light-blue coagulation tubes contain citrate and require the specified fill to preserve the blood-to-anticoagulant ratio.^[5]

Red top versus gold or tiger top

A red cap does not always mean “no additive.” BD product 367815, for example, is a plastic red-closure serum tube containing clot activator. Gold or tiger serum separator formats combine the specified clotting chemistry with a gel barrier. Both belong to the serum group, but gel suitability and clotting or processing requirements must match the assay. Do not assume a serum separator tube can replace every red-top tube.^[6][4]

Green, lavender and gray tubes

Green heparin tubes and lavender EDTA tubes are anticoagulant formats, but they serve different specimen requirements. Mayo Clinic Laboratories’ CBC listing specifies lavender-top EDTA whole blood; its cited HbA1c assay also uses EDTA. Neither example makes EDTA suitable for every chemistry test.^[9][10]

Two laboratory examples: Mayo Clinic Laboratories’ serum lipid panel lists serum gel as preferred and red top as acceptable. St. Clair Hospital’s plasma basic metabolic panel specifies lithium-heparin plasma and lists light-green PST as preferred. These examples explain the chart; the receiving laboratory’s own test directory controls the actual order.^[17][18]

In a fluoride/oxalate gray tube, fluoride inhibits glycolysis and oxalate provides anticoagulation. Sodium fluoride does not immediately stop glycolysis after collection. Other glucose-tube formulations exist. Follow the receiving laboratory’s validated separation, transport and time requirements for the actual product; cap color does not establish specimen stability.^[13][16]

3. Why Does the Phlebotomy Order of Draw Matter?

The purpose is to limit additive contamination of specimens collected for other tests. Potassium EDTA contamination, for example, can increase measured potassium and lower measured calcium. That combination can misrepresent the patient’s condition and trigger investigation or another collection.^[7]

The risk needs accurate wording. Mayo’s evidence discussion distinguishes closed evacuated collection from syringe transfer and direct pouring. A sequence error does not prove that contamination occurred, and contamination is not an inevitable consequence of every out-of-order tube. Continue to follow the validated order, record a deviation and involve the laboratory when specimen suitability is uncertain.^[7]

Order is one part of collection quality. It cannot compensate for an incorrect patient label, an underfilled citrate tube, poor mixing or unsuitable transport. Preventing those problems helps reduce avoidable repeat collections and delays; no sequence guarantees an accurate result on its own.

4. Light-Blue Tube Filling: The 9:1 Ratio and Underfill Problem

Routine coagulation collection commonly uses 3.2% buffered sodium citrate. The target is nine parts blood to one part citrate anticoagulant, rather than nine parts plasma. Underfilling changes that ratio and can produce inaccurate coagulation results.^[5]

• Read the exact tube’s fill requirement. Tube dimensions and nominal capacity do not replace the labeled draw volume or fill indicator.
• Check the collected volume against the approved criterion. Do not accept a partly filled tube solely because there appears to be enough material for the analyzer.
• Resolve an underfill through the laboratory. Do not combine separate citrate specimens, pour blood from another additive tube into it or add water to reach the line.
• Flag hematocrit above 55%. ARUP’s guidance calls for citrate adjustment in this situation. Arrange the laboratory’s controlled collection process; do not improvise an adjustment at the bedside.

The receiving laboratory determines acceptance and recollection requirements for the ordered assay. A general website percentage must not replace its validated criteria.

5. When Does a Butterfly Needle Need a Discard Tube?

When a winged blood collection set is used for venipuncture and a citrate tube is the first tube needed, collect a discard tube first. BD explains that the discard clears air in the tubing so the citrate tube can receive the intended blood volume. This is a tubing-volume issue, not a rule to discard blood before every venipuncture.^[3]

Discard requirements also differ by assay: ARUP’s hemostasis instructions recommend a pilot tube for coagulation testing other than PT/INR and aPTT. That laboratory-specific instruction is distinct from the winged-set air rule. The required discard container and volume come from the applicable procedure.^[5]

6. Mixing and Processing: Why There Is No Universal Inversion Count

Mix additive tubes promptly using gentle, complete inversions as instructed. Greiner Bio-One describes one inversion as turning the tube upside down and returning it upright; its chart assigns different counts to different tube types. A no-additive tube and a clot-activator serum tube do not have identical mixing requirements.^[4]

Read the current instructions for the exact manufacturer and product reference (REF), together with the laboratory’s validated procedure. Do not apply “invert everything eight to ten times” to every brand and tube. Vigorous shaking is not a substitute for gentle mixing.

Processing is a separate check. Confirm any clotting interval, centrifugation conditions, separation deadline and storage temperature for the assay. A correctly ordered and mixed specimen still needs the correct preparation and transport.^[8]

7. Special Tube Colors: Royal Blue, Pink, Pearl and Yellow

Place special tubes by the verified additive and test instructions. Do not insert them into the sequence using cap color alone.

• Royal blue: trace-element tubes exist with different additives. Mayo’s metals instructions place the royal-blue tube first within its additive group. Trace-element work also requires the specified collection and transfer materials.^[11]
• Pink and pearl: CLSI includes these as examples within the EDTA group. The particular product’s gel, intended use and test acceptance still need confirmation.^[1]
• Yellow: BD lists yellow-closure products containing ACD and other yellow-closure products containing SPS. Those are different additives, so “yellow goes first” is not a complete instruction.^[12]

If the test directory specifies a special kit or preservative tube, obtain its collection instructions before the draw. An unlisted tube is not automatically a gray-tube equivalent or the last tube.

8. Is the Capillary Order of Draw the Same?

No. Do not apply this venous chart to finger-stick or heel-stick collection. Capillary sampling uses separate procedures and microcollection devices. CLSI addresses diagnostic capillary blood specimens in GP42, separately from its PRE02 venous standard.^[14]

Before a capillary collection, confirm the microcollection system, the required specimens and any blood-gas requirements using the relevant laboratory and device instructions. A chart for evacuated venous tubes does not supply those directions. Line draws and specialized collection kits likewise need their own procedures.

9. Common Collection Mistakes and What to Do Next

This follow-up table synthesizes manufacturer handling guidance and laboratory specimen requirements.^{[3][4][5][7][8]}

Aliquotting is different. An authorized laboratory procedure can require transferring properly processed serum or plasma into a specified transport container. That controlled step must not be confused with pouring anticoagulated whole blood into a different collection tube to change its identity.^[8]

10. Patient Identification, Comfort and Collection Safety

Before collection, trained personnel reconcile the patient, request and required specimens, explain the procedure and check relevant preparation requirements. Follow the facility’s patient-identification and specimen-labeling process, with the required identifiers, collection details and verification at the collection site.^[8][15]

Use an appropriate collection device for the patient and ordered tests. The smallest available needle is not a universal solution for comfort or sample quality. Follow hand-hygiene, skin-preparation, single-use device, safety-mechanism and sharps-disposal procedures; never improvise a syringe-transfer method.

Patients can help by reporting previous fainting, difficult draws or adhesive sensitivities and by following the clinician’s preparation instructions. Multiple tubes often provide different specimen types for different tests; they do not necessarily mean multiple needle punctures. Correct collection supports useful results while reducing avoidable repeat procedures.

11. An Order of Draw Mnemonic That Tracks Additives

This recall phrase follows the six routine groups. It avoids making red and gold compulsory separate steps or treating every yellow cap as the same additive. Use it to remember the reference sequence, then verify the actual tube label and applicable protocol.

12. Download a Tube and Collection-Requirements Verification Sheet

Our original blank worksheet connects an ordered specimen to the exact tube, current instructions and unresolved questions. It is useful when updating a collection station, comparing an offered alternative or preparing a laboratory-approved reference.

TUBE ADDITIVE & COLLECTION REQUIREMENTS VERIFICATION SHEET
Original blank editorial resource | One exact REF / test requirement per record

RECORD CONTROL
Organization / collection area:
Prepared by / date:
Laboratory contact / procedure reference / revision:

ORDERED SPECIMEN AND PRODUCT IDENTITY
Test name / laboratory test code:
Required specimen: whole blood / serum / plasma / culture / other:
Legal manufacturer / brand:
Exact product REF / catalog number:
Closure color (visual cue only):
Labeled additive and concentration:
Separator gel: yes / no / type:
Tube material / dimensions:
Labeled draw volume / fill indicator:
Lot / expiry / storage conditions:

COLLECTION AND HANDLING EVIDENCE
Current manufacturer IFU title / revision / source:
Receiving laboratory test-directory entry / date checked:
Applicable venous / capillary / line / special-kit procedure:
Additive group and validated order placement:
Collection device / holder / winged set and exact REF:
Discard needed? Condition / container / required volume / procedure source:
Acceptable fill criterion and source:
Gentle inversion requirement / count / source:
Clotting interval if applicable:
Processing / centrifugation / aliquot-container requirements:
Time limits / temperature / transport / light protection:
Identification and labeling procedure reference:
Special hematocrit or other laboratory-directed requirements:

COMPARISON OR FOLLOW-UP
Requested REF / offered alternative, if relevant:
Differences in additive, volume, gel, material or handling:
Missing evidence / questions for the laboratory or manufacturer:
Decision: unresolved / hold / accepted under referenced procedure / reject:
Qualified reviewer / role / date / approval reference:
Next review trigger / action owner:

METHOD AND LIMITS
Record the current IFU and receiving laboratory's requirements together.
Resolve conflicting instructions through qualified laboratory review.
This blank worksheet is not a completed QC record, validated clinical SOP,
proof of sterility, or authorization to substitute products. Do not include
patient names, identifiers or test results in this resource.